Top 10 Companies in the (S)-2-Azetidinecarboxylic acid (CAS 2033-34-8) Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (S)-2-Azetidinecarboxylic acid (CAS 2033-34-8) market size was valued at USD 18.6 million in 2025. The market is projected to grow from USD 19.8 million in 2026 to USD 34.2 million by 2034, exhibiting a CAGR of 7.1% during the forecast period.

(S)-2-Azetidinecarboxylic acid is a non-proteinogenic amino acid and a four-membered ring analog of proline, distinguished by its azetidine ring structure and a carboxylic acid functional group. It is recognized for its role as a proline antagonist and is widely utilized as a chiral building block in the synthesis of pharmaceuticals, peptidomimetics, and biologically active compounds. Its high optical purity and conformational rigidity make it particularly valuable in medicinal chemistry and asymmetric synthesis applications.

The market is steadily gaining traction driven by increasing demand for chiral intermediates in drug discovery and the expanding pipeline of peptide-based therapeutics globally. Furthermore, growing research activity in the fields of chemical biology and synthetic organic chemistry continues to support consumption of specialty amino acid derivatives such as (S)-2-Azetidinecarboxylic acid. Key suppliers operating in this space include Sigma-Aldrich (Merck KGaA), TCI Chemicals, and Combi-Blocks, among others, offering the compound across research and commercial-grade specifications.

(S)-2-Azetidinecarboxylic acid (CAS 2033-34-8) Market – View in Detailed Research Report

Top 10 Companies

1️⃣ Pharmablock Sciences

Headquarters: Shanghai, China
Key Offering: High‑purity (S)-Azetidinecarboxylic acid for pharmaceutical intermediates

Pharmablock Sciences specializes in scalable asymmetric synthesis of strained‑ring amino acids, providing enantiomerically pure (S)-azetidine derivatives to leading pharma R&D labs. Their proprietary catalytic platform delivers >98% ee with high yields, supporting complex peptide and peptidomimetic projects.

Sustainability & Growth Initiatives:

• Investing in green, solvent‑free catalytic processes
• Expanding GMP‑certified facilities in Shanghai and Shenzhen
• Collaborating with CROs to accelerate custom synthesis pipelines

2️⃣ Biosynth Carbosynth

Headquarters: Basel, Switzerland
Key Offering: Research‑grade (S)-Azetidinecarboxylic acid and derivative library

Biosynth Carbosynth offers a comprehensive catalog of chiral amino acids, with (S)-azetidine as a core building block for peptidomimetic screening. Their high‑throughput synthesis platform supports academic and industrial discovery programs.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for precursor synthesis
• ISO 9001 and ISO 14001 certifications across production lines
• Strategic partnerships with European pharma manufacturers

3️⃣ Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Custom synthesis of (S)-Azetidinecarboxylic acid for drug discovery

Enamine’s expertise in biocatalytic routes enables cost‑effective production of (S)-azetidine, catering to CROs and early‑stage biotech firms seeking enantiomerically pure intermediates for lead optimization.

Sustainability & Growth Initiatives:

• Development of enzyme‑based asymmetric synthesis
• Integration of digital workflow for order management
• Expansion into Eastern European markets

4️⃣ Tokyo Chemical Industry

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical‑grade (S)-Azetidinecarboxylic acid and specialty intermediates

TCI’s advanced synthesis infrastructure supports large‑scale production of high‑purity (S)-azetidine, meeting stringent GMP requirements for API development in Japan and Asia‑Pacific.

Sustainability & Growth Initiatives:

• Investment in catalytic asymmetric reactors
• Eco‑friendly waste reduction programs
• Collaboration with Japanese universities for academic research

5️⃣ Synthonix Inc.

Headquarters: San Francisco, USA
Key Offering: High‑purity (S)-Azetidinecarboxylic acid and novel derivative libraries

Synthonix focuses on innovative scaffold design, providing (S)-azetidine derivatives that enhance metabolic stability in peptide therapeutics. Their platform supports rapid synthesis and screening for oncology and CNS indications.

Sustainability & Growth Initiatives:

• Biocatalytic process development for greener synthesis
• Partnerships with biotech incubators
• Investment in AI‑driven reaction optimization

6️⃣ Apollo Scientific Ltd.

Headquarters: London, UK
Key Offering: Research‑grade (S)-Azetidinecarboxylic acid for peptidomimetic studies

Apollo Scientific supplies high‑purity (S)-azetidine to academic labs and pharma R&D, emphasizing rigorous quality control and rapid turnaround.

Sustainability & Growth Initiatives:

• Implementation of ISO 9001 quality systems
• Carbon‑neutral production processes
• Strategic alliances with European CROs

7️⃣ Oakwood Chemical

Headquarters: San Diego, USA
Key Offering: Commercial‑grade (S)-Azetidinecarboxylic acid for API synthesis

Oakwood Chemical offers bulk (S)-azetidine with strict GMP compliance, catering to large‑scale pharma manufacturers and contract synthesis houses.

Sustainability & Growth Initiatives:

• Process intensification for higher yield
• Renewable energy usage in production facilities
• Collaboration with U.S. pharma giants

8️⃣ Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research and commercial (S)-Azetidinecarboxylic acid

Capot Chemical delivers a range of (S)-azetidine grades, supporting both academic research and industrial API development with flexible packaging options.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles
• Scale‑up of asymmetric catalytic processes
• Partnerships with Chinese biotech clusters

9️⃣ Hairui Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: High‑purity (S)-Azetidinecarboxylic acid for research and pharma

Hairui Chemical focuses on cost‑effective production of (S)-azetidine, leveraging in‑house catalytic expertise and providing rapid delivery to CROs and academic institutions.

Sustainability & Growth Initiatives:

• Investment in catalytic process optimization
• Implementation of ISO 14001 environmental management
• Expansion into Southeast Asian markets

🔟 Prime Molecular Co., Ltd.

Headquarters: Shenzhen, China
Key Offering: Commercial and custom (S)-Azetidinecarboxylic acid

Prime Molecular provides (S)-azetidine in bulk and custom grades, supporting global pharma R&D and contract synthesis with a focus on rapid scale‑up and high purity.

Sustainability & Growth Initiatives:

• Adoption of energy‑efficient reactors
• Green solvent usage in synthesis
• Collaboration with Chinese pharmaceutical companies

Download FREE Sample Report: (S)-2-Azetidinecarboxylic acid (CAS 2033-34-8) Market – View in Detailed Research Report

Get Full Report Here: (S)-2-Azetidinecarboxylic acid (CAS 2033-34-8) Market – View in Detailed Research Report

Outlook

The (S)-2-Azetidinecarboxylic acid market is poised for robust growth, driven by the expanding peptide therapeutics pipeline and the increasing adoption of constrained amino acids in drug discovery. Advances in asymmetric synthesis and green chemistry are reducing production costs, while strategic partnerships between suppliers and CROs are accelerating the translation of research findings into clinical candidates. Regulatory emphasis on chiral purity further supports market expansion, positioning (S)-azetidine as a critical building block for next‑generation therapeutics.

Future Trends

• Integration of (S)-azetidine derivatives in stapled peptide and macrocyclic drug candidates
• Expansion of biocatalytic and enzymatic synthesis routes for greener production
• Growth of custom synthesis services in Asia‑Pacific, particularly China and India
• Emerging applications in collagen‑mimetic biomaterials and tissue engineering
• Enhanced digital platforms for order management and supply chain transparency